MaaT Pharma SA (EPA:MAAT)
7.30
-0.38 (-4.95%)
At close: Jan 30, 2026
MaaT Pharma Employees
MaaT Pharma had 65 employees as of June 30, 2025. The number of employees decreased by 2 or -2.99% since the number was reported on December 31, 2024.
Employees
65
Change
-2
Growth
-2.99%
Revenue / Employee
€60,338
Profits / Employee
€478,969
Market Cap
117.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 65 | -2 | -2.99% | 65 | 0 |
| Dec 31, 2024 | 67 | 7 | 11.67% | 59 | 8 |
| Dec 31, 2023 | 60 | 9 | 17.65% | 52 | 8 |
| Dec 31, 2022 | 51 | 14 | 37.84% | 51 | 0 |
| Dec 31, 2021 | 37 | 4 | 12.12% | 37 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| Genfit | 188 |
| Innate Pharma | 181 |
| Transgene | 147 |
| Adocia | 77 |
| Sensorion | 68 |
| OSE Immunotherapeutics | 64 |
| Fermentalg | 63 |